Navigation Links
Glybera(TM) Shows Long-Term Health Benefits
Date:6/17/2009

hat the white colouring of blood vessels in het eyes of patients (lipemia retinalis) disappeared after administration of GlyberaTM showing that this gene therapy lowers the chylomicron levels in the blood. The disease can result in difficult-to-treat diabetes and is associated with significant morbidity and mortality.

About Amsterdam Molecular Therapeutics

AMT has a unique production platform that circumvents the obstacles that have hindered development of gene therapy technologies into drugs. Using adeno-associated viral vectors as the delivery vehicle of choice for therapeutic genes, the company has designed and validated a stable, scalable, commercially attractive and GMP-compliant AAV manufacturing platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with nine products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's business, including, but not limited to, the timely commencement and success of AMT's clinical trials and res
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... and sale of patented biopharmaceutical medicine, modernized traditional Chinese ... today announced the business and development progress at its ... Following the September 2014 JCM application (No. 51268) for ...
(Date:1/22/2015)... , Jan. 22, 2015  BiOptix is pleased to announce ... Vice President of Chemistry and Biochemistry. Scott joins the company ... Pharmaceuticals, and Amgen throughout the course of his nearly ... "Scott is a nationally recognized thought leader in ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... 8, 2011 Elsevier, world-leading provider of ... pleased to announce Dr. Steven Schachter, Editor-in-Chief of Elsevier,s ... the prestigious Ambassador for Epilepsy Award by the International ... Epilepsy (ILAE) at the 29 th International ...
... 2011 Marshall Edwards, Inc. (Nasdaq: MSHL ... of novel therapeutics targeting cancer metabolism, announced today the ... Company,s lead drug candidate ME-143 in patients with refractory ... with the Sarah Cannon Research Institute in Nashville, Tennessee, ...
Cached Medicine Technology:Editor-in-Chief of Elsevier's Epilepsy & Behavior presented with Ambassador for Epilepsy Award 2Editor-in-Chief of Elsevier's Epilepsy & Behavior presented with Ambassador for Epilepsy Award 3Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding ... its latest collection of wedding dresses , and launches a ... the wedding dress on your big day; the wedding gown ... bride wants to find the most suitable wedding dress. Now, ...
(Date:1/22/2015)... January 22, 2015 Lower-Auto-Insurance.com has released a new ... in a car for reducing the costs of an auto ... also be able to get lower prices for their vehicle insurance ... important role in determining policy costs. Because of this, drivers ...
(Date:1/22/2015)... State Forestry Institute of Mecklenburg-Vorpommern in Germany ... from GEOSYSTEMS, a dedicated Hexagon Geospatial and Intergraph partner ... Geospatial’s ERDAS APOLLO for cataloging, managing, and ... clouds and documents. This effort will enable the State ...
(Date:12/26/2014)... is said that nothing makes a lady feel more feminine ... supplier, shows its new selection of navy cocktail dresses ... UWDress.com’s navy cocktail gowns are the cornerstones of the site’s ... Simple dresses in bright neon colors can be dressed up ...
Breaking Medicine News(10 mins):Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... ... exams to uninsured diabetic patients. , ... Detroit, MI (Vocus) December 7, 2009 -- Mercy Primary Care Center of Detroit ... for the center’s diabetes management program serving uninsured residents in the city. In an effort ...
... , CAMP HILL, Pa., Dec. 7 Highmark ... organizations in which Highmark employees volunteer. Through Highmark,s Employee ... benefit the agencies they hold close to their hearts ... program reinforces the company,s appreciation for employees who volunteer ...
... , Advisory articles ... , HARRISBURG, Pa., Dec. 7 All Pennsylvania registered nurses can ... Safety Advisory articles that are posted on the Pennsylvania State ... law requires registered nurses to have 30 hours of continuing education ...
... successfully performed kidney transplants after removing small cancerous and ... results in the December issue of the urology journal ... at the University of Maryland School of Medicine in ... end-stage renal disease as well as increasing the supply ...
... , ... experts at Kroll Fraud Solutions will host a webinar that outlines important steps healthcare ... for Economic and Clinical Health Act (HITECH) , ... Nashville, TN (PRWEB) December 7, 2009 -- Data security ...
... ... consultancy, to offer top-of-the-line implementation services to Talyst’s clients in the acute care ... ... Clinical Meeting of the American Society of Health-System Pharmacists in Las Vegas, Talyst ...
Cached Medicine News:Health News:Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program, 2Health News:Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program, 3Health News:Highmark Inc. Employees Earn $7,000 for Nonprofit Organizations 2Health News:PA Registered Nurses Can Earn Continuing Education Hours Through Pennsylvania Patient Safety Advisories 2Health News:Controversial kidney transplant technique could provide lifeline for very ill patients 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:Talyst and RXinnovate Partner on Pharmacy Automation Implementation 2
... The Deluxe specimen bath mounts inside the ... bath allows for the separation of buffer and ... The bath can be sterilized and has round ... mounting specimens. The disks and bath surface ...
... A simple device designed to mount ... This product facilitates the mounting of all ... It is especially useful for mounting tissue ... as those produced with a Vibratome, freezing ...
Punch set for Advanced Tissue Arrayer, 0.6 mm...
Inquire...
Medicine Products: